Malignant carcinomas are often characterized by metastasis, the movement of carcinoma cells from a primary site to colonize distant organs. For metastasis to occur, carcinoma cells …
D Yao, C Li, MSR Rajoka, Z He, J Huang, J Wang… - Theranostics, 2020 - ncbi.nlm.nih.gov
Abstract The p21-Activated kinase 1 (PAK1), a member of serine-threonine kinases family, was initially identified as an interactor of the Rho GTPases RAC1 and CDC42, which affect a …
H Liu, K Liu, Z Dong - Frontiers in cell and developmental biology, 2021 - frontiersin.org
The p21-activated kinases (PAKs), downstream effectors of Ras-related Rho GTPase Cdc42 and Rac, are serine/threonine kinases. Biologically, PAKs participate in various cellular …
N Brindani, LM Vuong, IM Acquistapace… - Journal of Medicinal …, 2023 - ACS Publications
CDC42 GTPases (RHOJ, CDC42, and RHOQ) are overexpressed in multiple tumor types and activate pathways critical for tumor growth, angiogenesis, and metastasis. Recently, we …
In the current work, we designed and synthesized three families of non-fused and fused compounds based on cyanopyridone: derivatives of 6-amino-1, 2-dihydropyridine-3, 5 …
AC Cannon, C Uribe-Alvarez, J Chernoff - Trends in cancer, 2020 - cell.com
Small GTPases of the RAS and RHO families are related signaling proteins that, when activated by growth factors or by mutation, drive oncogenic processes. While activating …
G Semenova, J Chernoff - Biochemical Society Transactions, 2017 - portlandpress.com
p21-Activated kinase 1 (PAK1) has attracted much attention as a potential therapeutic target due to its central role in many oncogenic signaling pathways, its frequent dysregulation in …
C Champion, R Gall, B Ries, SR Rieder… - Journal of Chemical …, 2023 - ACS Publications
Alchemical free-energy methods based on molecular dynamics (MD) simulations have become important tools to identify modifications of small organic molecules that improve …
R Tesch, M Rak, M Raab, LM Berger… - Journal of Medicinal …, 2021 - ACS Publications
Salt-inducible kinases (SIKs) are key metabolic regulators. The imbalance in SIK function is associated with the development of diverse cancers, including breast, gastric, and ovarian …